SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma reports 20% rise in Q3 consolidated net profit

08 Feb 2019 Evaluate

Aurobindo Pharma has reported results for third quarter ended December 31, 2018.

The company has reported a rise of 4.32% in its net profit at Rs 463.51crore for the quarter under review as compared to Rs 444.32 crore for the same quarter in the previous year. Total income of the company increased by 24.44% at Rs 3384.97 crore for Q3FY19 as compared Rs 2720.07 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 19.70% in its net profit at Rs 712.22 crore for the quarter under review as compared to Rs 595.01 crore for the same quarter in the previous year. Total income of the company increased by 22.07% at Rs 5,333.52 crore for Q3FY19 as compared Rs 4,369.16 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1372.00 -13.65 (-0.99%)
20-Apr-2026 12:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.50
Dr. Reddys Lab 1238.75
Cipla 1240.00
Zydus Lifesciences 942.95
Lupin 2336.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×